CSNpharm
Tirapazamine is an experimental anticancer drug that is activated to a toxic radical only at very low levels of oxygen.
More Information
Supplier Page
CSNpharm
Tiratricol is a thyroid hormone analog with hepatic, has been used to suppress pituitary TSH secretion, with attenuation of extrapituitary thyromimetic effects.
More Information
Supplier Page
CSNpharm
Tiratricol is a thyroid hormone analog with hepatic, has been used to suppress pituitary TSH secretion, with attenuation of extrapituitary thyromimetic effects.
More Information
Supplier Page
CSNpharm
Tirofiban is a non-peptide reversible antagonist of the platelet integrin glycoprotein (GP) IIb/IIIa receptor used as an antiplatelet drug.
More Information
Supplier Page
CSNpharm
Tirofiban is a non-peptide reversible antagonist of the platelet integrin glycoprotein (GP) IIb/IIIa receptor used as an antiplatelet drug.
More Information
Supplier Page
CSNpharm
Tirofiban is a non-peptide reversible antagonist of the platelet integrin glycoprotein (GP) IIb/IIIa receptor used as an antiplatelet drug.
More Information
Supplier Page
CSNpharm
Tirofiban HCl H2O is a non-peptide reversible antagonist of the platelet integrin glycoprotein (GP) IIb/IIIa receptor used as an antiplatelet drug.
More Information
Supplier Page
CSNpharm
Tirofiban HCl H2O is a non-peptide reversible antagonist of the platelet integrin glycoprotein (GP) IIb/IIIa receptor used as an antiplatelet drug.
More Information
Supplier Page
CSNpharm
Tirofiban HCl H2O is a non-peptide reversible antagonist of the platelet integrin glycoprotein (GP) IIb/IIIa receptor used as an antiplatelet drug.
More Information
Supplier Page
CSNpharm
Tirofiban HCl H2O is a non-peptide reversible antagonist of the platelet integrin glycoprotein (GP) IIb/IIIa receptor used as an antiplatelet drug.
More Information
Supplier Page
CSNpharm
Tirofiban HCl H2O is a non-peptide reversible antagonist of the platelet integrin glycoprotein (GP) IIb/IIIa receptor used as an antiplatelet drug.
More Information
Supplier Page
CSNpharm
Tizanidine is an α2-adrenergic receptor agonist and inhibits neurotransmitter release from CNS noradrenergic neurons.
More Information
Supplier Page
CSNpharm
Tizanidine is an α2-adrenergic receptor agonist and inhibits neurotransmitter release from CNS noradrenergic neurons.
More Information
Supplier Page
CSNpharm
Tizanidine is an α2-adrenergic receptor agonist and inhibits neurotransmitter release from CNS noradrenergic neurons.
More Information
Supplier Page
CSNpharm
Tiamenidine HCl is a centrally-acting α1 and α2 adrenergic receptor antagonist with IC50 4.85 μM and 0.0091 μM, respectively, for the management of essential hypertension.
More Information
Supplier Page
CSNpharm
Tiamenidine HCl is a centrally-acting α1 and α2 adrenergic receptor antagonist with IC50 4.85 μM and 0.0091 μM, respectively, for the management of essential hypertension.
More Information
Supplier Page
CSNpharm
Tiamenidine HCl is a centrally-acting α1 and α2 adrenergic receptor antagonist with IC50 4.85 μM and 0.0091 μM, respectively, for the management of essential hypertension.
More Information
Supplier Page
CSNpharm
Tizoxanide is an active metabolite of Nitazoxanide with inhibitory effect against hepatitis B virus and hepatitis C virus.
More Information
Supplier Page
CSNpharm
Tizoxanide is an active metabolite of Nitazoxanide with inhibitory effect against hepatitis B virus and hepatitis C virus.
More Information
Supplier Page
CSNpharm
Tizoxanide is an active metabolite of Nitazoxanide with inhibitory effect against hepatitis B virus and hepatitis C virus.
More Information
Supplier Page
CSNpharm
Tizoxanide is an active metabolite of Nitazoxanide with inhibitory effect against hepatitis B virus and hepatitis C virus.
More Information
Supplier Page
CSNpharm
TLX agonist 1 (ccrp2) is an orphan nuclear receptor tailless (TLX, NR2E1) modulator with EC50 of 1μM and Kd of 650 nM.
More Information
Supplier Page
CSNpharm
TLX agonist 1 (ccrp2) is an orphan nuclear receptor tailless (TLX, NR2E1) modulator with EC50 of 1μM and Kd of 650 nM.
More Information
Supplier Page
CSNpharm
TLX agonist 1 (ccrp2) is an orphan nuclear receptor tailless (TLX, NR2E1) modulator with EC50 of 1μM and Kd of 650 nM.
More Information
Supplier Page
CSNpharm
TLX agonist 1 (ccrp2) is an orphan nuclear receptor tailless (TLX, NR2E1) modulator with EC50 of 1μM and Kd of 650 nM.
More Information
Supplier Page
CSNpharm
TLX agonist 1 (ccrp2) is an orphan nuclear receptor tailless (TLX, NR2E1) modulator with EC50 of 1μM and Kd of 650 nM.
More Information
Supplier Page
TMB
250mg
| ≥99%
CSNpharm
TMB, a chromogenic substrate, is used in staining procedures in immunohistochemistry as well as being a visualising reagent used in enzyme-linked immunosorbent assays (ELISA).
More Information
Supplier Page
CSNpharm
TMB 2HCl is a chromogenic substrate used in staining procedures in immunohistochemistry as well as being a visualising reagent used in enzyme-linked immunosorbent assays (ELISA).
More Information
Supplier Page
CSNpharm
TMB 2HCl is a chromogenic substrate used in staining procedures in immunohistochemistry as well as being a visualising reagent used in enzyme-linked immunosorbent assays (ELISA).
More Information
Supplier Page
CSNpharm
TMB monosulfate is a chromogenic substrate used in staining procedures in immunohistochemistry and also act as a visualizing reagent used in enzyme-linked immunosorbent assays (ELISA).
More Information
Supplier Page
CSNpharm
TMBIM6 antagonist-1, a potential TMBIM6 antagonist, prevents TMBIM6 binding to mTORC2, decreases mTORC2 activity, and also regulates TMBIM6-leaky Ca2+.
More Information
Supplier Page
CSNpharm
TMBIM6 antagonist-1, a potential TMBIM6 antagonist, prevents TMBIM6 binding to mTORC2, decreases mTORC2 activity, and also regulates TMBIM6-leaky Ca2+.
More Information
Supplier Page
CSNpharm
TMBIM6 antagonist-1, a potential TMBIM6 antagonist, prevents TMBIM6 binding to mTORC2, decreases mTORC2 activity, and also regulates TMBIM6-leaky Ca2+.
More Information
Supplier Page
CSNpharm
TMBIM6 antagonist-1, a potential TMBIM6 antagonist, prevents TMBIM6 binding to mTORC2, decreases mTORC2 activity, and also regulates TMBIM6-leaky Ca2+.
More Information
Supplier Page
TMCB
1mg
| ≥98%
CSNpharm
TMCB is a dual-kinase inhibitor of both casein kinase 2 (CK2) and extracellular-signal-regulated kinase 8 (ERK8) with IC50s of 0.50 μM.
More Information
Supplier Page
CSNpharm
TMPyP4 tosylate (TMP 1363) is a quadruplex-specific ligand, which inhibits the interaction between G-quadruplexes and IGF-1[1]. TMPyP4 tosylate (TMP 1363) is a telomerase inhibitor with antitumor effects in osteosarcoma cell lines[2].
More Information
Supplier Page
CSNpharm
TMPyP4 tosylate (TMP 1363) is a quadruplex-specific ligand, which inhibits the interaction between G-quadruplexes and IGF-1[1]. TMPyP4 tosylate (TMP 1363) is a telomerase inhibitor with antitumor effects in osteosarcoma cell lines[2].
More Information
Supplier Page
CSNpharm
TMPyP4 tosylate (TMP 1363) is a quadruplex-specific ligand, which inhibits the interaction between G-quadruplexes and IGF-1[1]. TMPyP4 tosylate (TMP 1363) is a telomerase inhibitor with antitumor effects in osteosarcoma cell lines[2].
More Information
Supplier Page
CSNpharm
TMPyP4 tosylate (TMP 1363) is a quadruplex-specific ligand, which inhibits the interaction between G-quadruplexes and IGF-1[1]. TMPyP4 tosylate (TMP 1363) is a telomerase inhibitor with antitumor effects in osteosarcoma cell lines[2].
More Information
Supplier Page
TMS
5mg
| ≥98%
CSNpharm
TMS
50mg
| ≥98%
CSNpharm
TMS
100mg
| ≥98%
CSNpharm
TMS
25mg
| ≥98%
CSNpharm
TMS
10mg
| ≥98%
CSNpharm
Tobramycin
25mg
| Purity Not Available
CSNpharm
Tobramycin
100mg
| Purity Not Available
CSNpharm
CSNpharm
CSNpharm
TOFA
100mg
| ≥98%
CSNpharm
TOFA
5mg
| ≥98%
CSNpharm